VRCA — Verrica Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $60.64m
- $50.84m
- $35.58m
Brief: Verrica Pharmaceuticals Reports Fourth Quarter And Full-Year 2022 Financial Results
U.S. STOCKS ON THE MOVE-VerifyMe, Molson Coors, Sigma Lithium
U.S. STOCKS ON THE MOVE-Chemomab, Home Depot, Teck Resources
U.S. STOCKS ON THE MOVE-General Mills, PayPal Holdings, defense stocks
Verrica Pharma slides on $32.5 mln stock offering
Brief: Verrica Announces Pricing Of $32.5 Million Underwritten Offering Of Common Stock And Pre-Funded Warrants
Brief: Verrica Pharma Reports Cash And Cash Equivalents
U.S. STOCKS ON THE MOVE-Baudax Bio , GATX Corp, Verb Technology, Decibel Therapeutics
U.S. STOCKS ON THE MOVE-PACCAR, Cullinan Oncology, 3M, Peloton
U.S. STOCKS ON THE MOVE-HighPeak Energy , CymaBay Therapeutics, Polypid
Verrica Pharma up on resubmission of marketing application for lead product
Brief: Verrica Pharmaceuticals Announces Technology Transfer Of Manufacturing Of VP-102 To Piramal Pharma Solutions
Brief: Verrica Pharmaceuticals Inc - May Offer And Sell Shares Of Our Common Stock Having An Aggregate Offering Price Of Up To $50 mln
Verrica Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary
Brief: Verrica Pharmaceuticals Inc Files For Mixed Shelf Of Up To $150 Mln - SEC Filing
Brief: Verrica Pharmaceuticals Reports Third Quarter 2022 Financial Results
Brief: Verrica Pharmaceuticals Posts Q2 Non-GAAP Loss Per Share $0.32
Brief: Verrica Pharmaceuticals Announces Start Of Phase 3 Trial Of VP-102 For The Treatment Of Molluscum Contagiosum By Torii Pharmaceutical Co In Japan
Brief: Verrica Pharmaceuticals Inc Says Co Voluntarily Repaid In Full Debt Outstanding Under Mezzanine Loan, Security Agreement